Case Study: LEAPs vs. Stock Ownership

Theory sounds good until you see the numbers. Let's take the same $10,000 and compare what happens when you buy stock versus when you buy LEAPs on the same company. Same money, same stock, same time frame, but very different outcomes. This case study shows exactly how leverage amplifies returns and why disciplined value investors use it selectively.

TL;DR

• Same capital, different exposure: $10,000 in stock buys 100 shares; $10,000 in LEAPs controls 500-700 shares depending on strike and premium
• Leverage multiplies gains: A 40% stock gain becomes a 200%+ LEAP gain, but a 20% stock drop can cut LEAP value by 60-80%
• Risk is capped with LEAPs: You can't lose more than the premium paid, unlike margin debt that exposes you to unlimited losses
• Time decay matters: Stock buyers don't lose value from waiting; LEAP buyers pay for time through theta decay
• Best for undervalued quality businesses: The math works when you're right about intrinsic value and give it 12-24 months to play out

Meet "SteadyCo": The Setup

Let's create a realistic scenario using a fictional company that fits value investing criteria.

Company: SteadyCo Inc.

• Current stock price: $100
• Your intrinsic value estimate: $140 (40% undervalued)
• Business quality: Strong free cash flow, 15% ROE, low debt, economic moat
• Your thesis: Market overreacted to short-term headwinds, fundamentals intact

You have $10,000 to invest. Two paths:

Path A: Buy Stock

• Buy 100 shares at $100 = $10,000
• You own the shares outright, no expiration, no time pressure

Path B: Buy LEAPs

• Buy $90 strike LEAPs (18 months to expiration) at $15 per share
• Each contract = 100 shares, costs $1,500
• You buy 6 contracts = 600 shares of exposure for $9,000
• Keep $1,000 in cash as dry powder

Let's see how both paths perform over 18 months.

Scenario 1: The Thesis Plays Out (Stock Rises to $140)

Path A Results (Stock):

• Starting position: 100 shares × $100 = $10,000
• Ending position: 100 shares × $140 = $14,000
• Gain: $4,000 (40% return)

Path B Results (LEAPs):

• Starting position: 6 contracts × $1,500 = $9,000 invested
• LEAP intrinsic value at expiration: $140 stock - $90 strike = $50 per share
• Ending position: 6 contracts × $50 × 100 shares = $30,000
• Cash held: $1,000 (untouched)
• Gain: $21,000 on LEAPs + $1,000 cash = $22,000 total (220% return on deployed capital, 147% return on total $10,000)

The stock buyer made a solid 40% return. The LEAP buyer made 220% on deployed capital. Same stock, same move, but the leverage amplified the outcome by 5.5x.

Why the difference? The LEAP buyer controlled 600 shares instead of 100 shares. When the stock gained $40 per share, that's $24,000 in total gains (600 × $40), minus the $9,000 premium paid = $15,000 net gain on LEAPs. Add the $1,000 cash back in, and you're at $22,000 total profit on the $10,000 initial capital.

Scenario 2: Patience Required (Stock Rises to $120)

Path A Results (Stock):

• Starting position: 100 shares × $100 = $10,000
• Ending position: 100 shares × $120 = $12,000
• Gain: $2,000 (20% return)

Path B Results (LEAPs):

• Starting position: 6 contracts × $1,500 = $9,000 invested
• LEAP intrinsic value at expiration: $120 stock - $90 strike = $30 per share
• Ending position: 6 contracts × $30 × 100 shares = $18,000
• Cash held: $1,000
• Gain: $9,000 on LEAPs + $1,000 cash = $10,000 total (100% return on deployed capital, 67% return on total $10,000)

The stock buyer made a respectable 20%. The LEAP buyer doubled their money. The stock moved halfway to your target, but leverage still amplified the outcome significantly.

Scenario 3: Market Stays Irrational (Stock Stays at $100)

Path A Results (Stock):

• Starting position: 100 shares × $100 = $10,000
• Ending position: 100 shares × $100 = $10,000
• Gain: $0 (0% return)

Path B Results (LEAPs):

• Starting position: 6 contracts × $1,500 = $9,000 invested
• LEAP intrinsic value at expiration: $100 stock - $90 strike = $10 per share
• But time value decayed to $0 (it's expiration day)
• Ending position: 6 contracts × $10 × 100 shares = $6,000
• Cash held: $1,000
• Loss: $3,000 on LEAPs, total portfolio = $7,000 (30% loss on total $10,000)

Here's where the cost of leverage shows up. The stock buyer broke even (no gain, no loss). The LEAP buyer lost 30% because time decay ate the $5 per share in time value that was baked into the original $15 premium.

This is why valuation must be right and timing must be reasonable. If the market takes 3 years to recognize value but your LEAP expires in 18 months, you lose even though the thesis was correct.

Scenario 4: Thesis Was Wrong (Stock Drops to $80)

Path A Results (Stock):

• Starting position: 100 shares × $100 = $10,000
• Ending position: 100 shares × $80 = $8,000
• Loss: $2,000 (20% loss)

Path B Results (LEAPs):

• Starting position: 6 contracts × $1,500 = $9,000 invested
• LEAP strike is $90, stock is $80 → out-of-the-money
• LEAPs expire worthless
• Cash held: $1,000
• Loss: $9,000 on LEAPs, total portfolio = $1,000 (90% loss on total $10,000)

This is the dark side of leverage. The stock buyer lost 20%. The LEAP buyer lost 90%. The same $20 drop amplified through leverage, and because the strike was $90 but the stock only reached $80, there's zero intrinsic value left at expiration.

But here's the key difference from margin debt: the LEAP buyer can't lose more than the $9,000 premium paid. A margin buyer with $20,000 of stock (using $10,000 borrowed) would face a $4,000 loss plus margin interest, and potentially a margin call forcing liquidation at the worst time.

The Math Behind the Amplification

Let's break down why the LEAP outcomes differ so dramatically from stock outcomes.

Stock buyer math:

• 100 shares × price change = dollar gain/loss
• Percentage return = (ending price - starting price) ÷ starting price

LEAP buyer math:

• 600 shares controlled × price change above strike = intrinsic value gain
• Subtract original premium paid ($9,000)
• Percentage return = net gain ÷ original premium

The LEAP buyer gets 6x the exposure (600 shares vs. 100 shares) but pays upfront for that leverage ($9,000). If the stock moves in your favor, the 6x exposure amplifies gains. If it moves against you or stays flat, the time decay and lack of intrinsic value amplifies losses.

Which Path Is Better?

There's no universal answer. It depends on your conviction, time horizon, and risk tolerance.

Choose stock ownership when:

• You want zero expiration risk and can hold forever
• You're uncertain about timing (stock might take 3-5 years to reach intrinsic value)
• You want dividends and voting rights
• You can't stomach 50-90% drawdowns on a position

Choose LEAPs when:

• You have high conviction about intrinsic value being 20-40% above current price
• You believe the market will recognize value within 12-24 months
• You want to control more shares with less capital and deploy the rest elsewhere
• You accept that you might lose 50-100% of the LEAP premium if timing is wrong

Many value investors do both: buy stock for core long-term holdings, and use LEAPs on 1-2 high-conviction ideas where timing looks favorable.

What Could Go Wrong?

Both paths have risks, but they're different:

• Stock risk: You tie up $10,000 in one company. If it drops 50%, you need a 100% gain to break even, and recovery could take years
• LEAP risk: You lose the entire premium if the stock doesn't move above your strike by expiration, even if you're eventually right
• Overallocation risk: Putting 100% of your capital into LEAPs (instead of the 90% shown here) leaves no dry powder for better opportunities
• Wrong valuation risk: If your intrinsic value estimate is off, leverage amplifies the mistake
• Impatience risk: Checking prices daily and panicking when LEAPs drop 30-40% during normal volatility leads to selling at the worst time

Mitigations: Only use LEAPs on stocks trading at least 20% below intrinsic value (cheat using Wall St. Yardie), limit LEAPs to 10-20% of your portfolio, choose 18-24 month expirations to give your thesis time, pick in-the-money strikes (delta 0.70+) to reduce out-of-the-money risk, and always keep 10-20% cash as dry powder.

Real-World Considerations

This case study simplifies a few things:

• Taxes: LEAP gains held less than 12 months are short-term capital gains (taxed as ordinary income). Stock gains held 12+ months are long-term capital gains (lower tax rate). Plan accordingly.
• Dividends: Stock buyers collect dividends. LEAP buyers don't. If SteadyCo pays a 2% annual dividend, the stock buyer earns an extra $200 over 18 months.
• Liquidity: LEAPs on small-cap stocks may have wide bid-ask spreads, increasing the real cost. Stick to liquid names with tight spreads.
• Rolling: If timing is wrong but fundamentals remain strong, LEAP buyers can "roll" to a later expiration, extending the thesis. Stock buyers don't need to do anything.

Next Steps

• Identify 2-3 high-conviction ideas: Use the Wall St. Yardie App to calculate intrinsic value and find stocks trading 20-40% below fair value
• Run your own case study: Model what happens with your actual capital on a stock you're considering, compare stock vs. LEAPs outcomes in 3 scenarios (bull, flat, bear)
• Paper trade first: Use a simulator to buy both stock and LEAPs on the same company, track performance for 6-12 months to see leverage in action without risking real money
• Start with 1 position: If LEAPs make sense, buy 1-2 contracts on a single stock before scaling up
• Read more: Check out Valuation Models Applied to LEAPs to ensure your intrinsic value estimates are solid, and Position Sizing with LEAPs to learn how to allocate capital across multiple positions safely